Corinne Johnson
Stock Analyst at Goldman Sachs
(0.12)
# 4,115
Out of 4,829 analysts
7
Total ratings
16.67%
Success rate
-20.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $27.87 | +111.70% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $20.15 | +88.59% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $23.74 | +110.62% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $14.02 | +256.63% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $27.87
Upside: +111.70%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $20.15
Upside: +88.59%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $23.74
Upside: +110.62%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $14.02
Upside: +256.63%